(Bloomberg) A world away from its steel-and-glass headquarters in London, GSK Plc is wading into unfamiliar waters: A mangrove nursery in coastal Indonesia that’s being nurtured to harbor crabs, fish — and carbon.
It’s the precious carbon GSK is really after, as it seeks to apply the mangroves’ carbon-capture prowess to nullify climate-warming gases emitted by its global network of factories and vehicles, and the many asthma inhalers it sells. The drugmaker, wary about the poor quality and questionable climate benefits of carbon offsets for sale on the open market from brokers, is now devising its own credits.
Read more here
Posted in Uncategorized